You searched for Parkinson's - Page 18 of 20

Best in Biotech 4 Jul 2025

14 biotech companies to know in the Boston area in 2025

…targeting neuroinflammation in Parkinson’s disease. Orna Therapeutics Founded: 2019 Focus area: Circular RNA therapies Lead candidate: In vivo CAR-T Orna Therapeutics is developing therapies using circular RNA, an alternative to…

July 4, 2025 - 15 minutesmins - By Jules Adam

Best in Biotech 20 Feb 2018

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

…loss in the brain. LMTX also inhibits the aggregation of TPD-43 (behavioral variant frontotemporal dementia), synuclein (Parkinson’s disease), and huntingtin proteins (Huntington’s disease). With 2016’s biggest fundraising round of €120M…

February 20, 2018 - 11 minutesmins - By Karen O’Hanlon Cohrt

Best in Biotech 2 May 2024

Eight monoclonal antibody biotechs making strides in the clinic

…BioArctic looks to counter is Parkinson’s disease. Its phase 1 candidate exidavenmab is a monoclonal antibody that binds to toxic forms of alpha-synuclein – a protein that can cause inflammation…

May 2, 2024 - 9 minutesmins - By Roohi Mariam Peter

silk fibroin biomaterial stroke stem cells

News and Trends 19 Nov 2018

Silk Biomaterial Could Regenerate the Brain After a Stroke

…as Parkinson’s and Alzheimer’s, eye diseases like glaucoma and age-related macular degeneration, the repair of skin and tendons, and the treatment of incontinence and impotence caused by prostate surgery. Images…

November 19, 2018 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 7 Feb 2020

EU Project Set up to Fight Alzheimer’s Disease with Lasers

…some symptoms of Parkinson’s disease. Unlike these other techniques, the project aims to target specific brain networks, rather than individual brain regions or cells. “We are focused on the knowledge…

February 7, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 24 Jan 2023

Ubiquigent and University of Glasgow to collaborate on drug discovery

…has been proposed as a therapeutic strategy for Parkinson’s disease (PD). Although numerous USP30-targeting compounds are reported in scientific literature, only one has been approved to enter clinical evaluation so…

January 24, 2023 - 3 minutesmins - By Jim Cornall

In Depth 20 Apr 2020

How Has Coronavirus Affected Europe’s Biotech Stocks?

…its registrational study of its Parkinson’s disease candidate.” While many drugs are being delayed, it is also noteworthy that governments worldwide are willing to offer a vaccine to their citizens…

April 20, 2020 - 12 minutesmins - By Carlos de Rojas

News and Trends 2 Mar 2023

Ten new companies join BioInnovation Institute’s Venture Lab program

…metastasis and determine the optimal chemotherapy; NorFalk, which produces sustainable surfactants; and Amplify Therapeutics, which is developing disease-modifying therapies for Gaucher disease and genetic subgroups of Parkinson’s disease. Since its…

March 2, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 10 Jul 2019

The Top 10 Biotechs You’ll Find in Lyon

…targeting neurons to enhance their effect. Founded in 2013, Theranexus has three drug candidates being tested in clinical trials to treat narcolepsy, sleepiness in Parkinson’s disease, Alzheimer’s, and neuropathic pain….

July 10, 2019 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 21 Mar 2025

Depression drug trials are failing—and placebos are to blame

…treatment-resistant depression. American healthcare company Abbott has begun a pivotal clinical trial, having previously been successful in helping manage Parkinson’s disease and essential tremor symptoms. Meanwhile, Neurocrine Biosciences has launched…

March 21, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 2 Mar 2023

Antiverse identifies therapeutic antibodies targeting GPCRs

…Scale, as well as existing investors, Tensor Ventures, Deep Science Ventures, Ed Parkinson and Development Bank of Wales (DBW). Murat Tunaboylu, co-founder and CEO of Antiverse, said: “This is the…

March 2, 2023 - 3 minutesmins - By Jim Cornall

huntingtons disease dementia prilenia therapeutics

News and Trends 5 Jun 2020

Israeli-Dutch Biotech Raises €55M to Fight Huntington’s Disease and ALS

…and the neurodegenerative condition Parkinson’s disease. “Pridopidine’s mechanism as a sigma-1 receptor agonist is relevant to multiple neurodegenerative diseases as it rescues cellular processes that are commonly impaired in several…

June 5, 2020 - 3 minutesmins - By Helen Albert

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

14 biotech companies to know in the Boston area in 2025

Money, Money, Money! Europe’s Best-Funded Biotechs in 2018

Eight monoclonal antibody biotechs making strides in the clinic

Silk Biomaterial Could Regenerate the Brain After a Stroke

EU Project Set up to Fight Alzheimer’s Disease with Lasers

Ubiquigent and University of Glasgow to collaborate on drug discovery

How Has Coronavirus Affected Europe’s Biotech Stocks?

Ten new companies join BioInnovation Institute’s Venture Lab program

The Top 10 Biotechs You’ll Find in Lyon

Depression drug trials are failing—and placebos are to blame

Antiverse identifies therapeutic antibodies targeting GPCRs

Israeli-Dutch Biotech Raises €55M to Fight Huntington’s Disease and ALS

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!